|
| 37494457 | Association of functional, inherited vitamin D-binding protein variants with melanoma-specific death. | JNCI Cancer Spectr | 2023 |
| 36805567 | Methylation of nonessential genes in cutaneous melanoma - Rule Out hypothesis. | Melanoma Res | 2023 |
| 36926987 | Pathway Alterations in Stage II/III Primary Melanoma. | JCO Precis Oncol | 2023 |
| 35286522 | Differences in somatic TP53 mutation type in breast tumors by race and receptor status. | Breast Cancer Res Treat | 2022 |
| 35701440 | Prognostic significance of RNA-based TP53 pathway function among estrogen receptor positive and negative breast cancer cases. | NPJ Breast Cancer | 2022 |
| 35876628 | Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study. | Pigment Cell Melanoma Res | 2022 |
| 34737209 | TP53 Pathway Function, Estrogen Receptor Status, and Breast Cancer Risk Factors in the Carolina Breast Cancer Study. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 34843679 | Characterization of the CpG Island Hypermethylated Phenotype Subclass in Primary Melanomas. | J Invest Dermatol | 2022 |
| 34607836 | Disease-Associated Risk Variants in <i>ANRIL</i> Are Associated with Tumor-Infiltrating Lymphocyte Presence in Primary Melanomas in the Population-Based GEM Study. | Cancer Epidemiol Biomarkers Prev | 2021 |
| 33661190 | Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922). | Melanoma Res | 2021 |
| 31533668 | Reproductive characteristics are associated with gene-specific promoter methylation status in breast cancer. | BMC Cancer | 2019 |
| 30211730 | Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis. | Am J Dermatopathol | 2019 |
| 30529013 | Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis. | J Invest Dermatol | 2019 |
| 30763347 | Reproductive characteristics modify the association between global DNA methylation and breast cancer risk in a population-based sample of women. | PLoS ONE | 2019 |
| 29753029 | Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes. | J Invest Dermatol | 2018 |
| 29133365 | Prediagnostic Smoking Is Associated with Binary and Quantitative Measures of ER Protein and mRNA Expression in Breast Tumors. | Cancer Epidemiology Biomarkers and Prevention | 2018 |
| 28275920 | Breast tumor DNA methylation patterns associated with smoking in the Carolina Breast Cancer Study. | Breast Cancer Research and Treatment | 2017 |
| 28695396 | Active smoking and survival following breast cancer among African American and non-African American women in the Carolina Breast Cancer Study. | Cancer Causes and Control | 2017 |
| 28842324 | Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma. | J Invest Dermatol | 2017 |
| 29608187 | Postdiagnosis Changes in Cigarette Smoking and Survival Following Breast Cancer. | JNCI Cancer Spectrum | 2017 |
| 27765798 | Environmental Tobacco Smoke Exposure and Survival Following Breast Cancer. | Cancer Epidemiology Biomarkers and Prevention | 2017 |
| 28052933 | Grilled, Barbecued, and Smoked Meat Intake and Survival Following Breast Cancer. | Journal of the National Cancer Institute | 2017 |
| 27741445 | Polycyclic aromatic hydrocarbons and postmenopausal breast cancer: An evaluation of effect measure modification by body mass index and weight change. | Environmental Research | 2017 |
| 26671626 | Sources of polycyclic aromatic hydrocarbons are associated with gene-specific promoter methylation in women with breast cancer. | Environmental Research | 2016 |
| 27153846 | Active smoking and risk of Luminal and Basal-like breast cancer subtypes in the Carolina Breast Cancer Study. | Cancer Causes and Control | 2016 |
| 26878284 | Exposure to multiple sources of polycyclic aromatic hydrocarbons and breast cancer incidence. | Environment international | 2016 |
| 26200835 | Rational Manual and Automated Scoring Thresholds for the Immunohistochemical Detection of TP53 Missense Mutations in Human Breast Carcinomas. | Applied Immunohistochemistry and Molecular Morphology | 2016 |
| 26146664 | Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma. | JAMA Oncol | 2015 |
| 25583948 | Body mass index is associated with gene methylation in estrogen receptor-positive breast tumors. | Cancer Epidemiology Biomarkers and Prevention | 2015 |
| 25809865 | Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study. | Cancer Epidemiology Biomarkers and Prevention | 2015 |
| 25953686 | Body mass index associated with genome-wide methylation in breast tissue. | Breast Cancer Research and Treatment | 2015 |
| 25934889 | IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma. | Clin Cancer Res | 2015 |
| 24986547 | DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features. | Pigment Cell and Melanoma Research | 2014 |
| 25287138 | DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival. | Breast Cancer Research | 2014 |
| 22198468 | Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). | Breast Cancer Res Treat | 2012 |
| 21375697 | DNA-methylation profiling distinguishes malignant melanomas from benign nevi. | Pigment Cell and Melanoma Research | 2011 |
| 20232134 | A case-control study of tobacco use and other non-occupational risk factors for lymphoma subtypes defined by t(14; 18) translocations and bcl-2 expression. | Cancer Causes Control | 2010 |
| 19505720 | Non-Hodgkin lymphoma (NHL) subtypes defined by common translocations: utility of fluorescence in situ hybridization (FISH) in a case-control study. | Leuk Res | 2010 |
| 20010862 | Melanoma molecular subtypes: unifying and paradoxical results. | | 2010 |
| 20043015 | Relationship between germline MC1R variants and BRAF-mutant melanoma in a North Carolina population-based study. | | 2010 |
| 20064791 | Associations between polycyclic aromatic hydrocarbon-related exposures and p53 mutations in breast tumors. | Environ Health Perspect | 2010 |
| 20407015 | Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivation. | Molecular Cancer Research | 2010 |
| 19521985 | FAK overexpression and p53 mutations are highly correlated in human breast cancer. | International Journal of Cancer | 2009 |
| 17578664 | Epidemiology of basal-like breast cancer. | Breast Cancer Res Treat | 2008 |
| 17553133 | Risk factors for breast cancer characterized by the estrogen receptor alpha A908G (K303R) mutation. | Breast Cancer Research | 2007 |
| 17507627 | Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma. | Cancer Epidemiology Biomarkers and Prevention | 2007 |
| 16332723 | IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. | Carcinogenesis | 2006 |
| 16757721 | Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. | JAMA | 2006 |
| 16652373 | DNA repair gene polymorphisms and probability of p53 mutation in bladder cancer. | Molecular Carcinogenesis | 2006 |
| 16434608 | No association between the MDM2 -309 T/G promoter polymorphism and breast cancer in African-Americans or Whites. | Cancer Epidemiology Biomarkers and Prevention | 2006 |